Skip to Main Content

Paper Details

Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
NPJ Breast Cancer
7
2022
Author NameAffiliation
Christina YauUniversity of California San Francisco
Christina YauUniversity of California San Francisco
Denise M WolfUniversity of California San Francisco
Judy C BougheyMayo Clinic Rochester
Rachel L YungUniversity of Washington
Claudine IsaacsUniversity of Georgetown
Rita NandaUniversity of Chicago
Minetta C LiuMayo Clinic Rochester
Emanuel F PetricoinGeorge Mason University
Emanuel F PetricoinGeorge Mason University
Scott M Berry
William F SymmansUniversity of Texas MD Anderson Cancer Center
Laura J Van't VeerUniversity of California San Francisco
Donald A Berry
  • 1 - 14

Datasets

Release 1.2